Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge

6 Jan 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Vector-Borne Animal Diseases
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20056185
DOI: 10.1016/j.vaccine.2009.12.062

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challengePMID 20056185Read ↗

Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infectionsSemantic proximity Read ↗

A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challengeSemantic proximity Read ↗

A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in catsSemantic proximity Read ↗

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa virusesSemantic proximity Read ↗

Comparative efficacy of two next-generation Rift Valley fever vaccinesSemantic proximity Read ↗

Subunit vaccine formulations based on recombinant envelope proteins of Chikungunya virus elicit balanced Th1/Th2 response and virus-neutralizing antibodies in miceSemantic proximity Read ↗

Emerging vector-borne flavivirus diseases: are vaccines the solution?Semantic proximity Read ↗

Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent modelsSemantic proximity Read ↗

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccinesSemantic proximity Read ↗

Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR−/− mice induced by different DNA vaccination regimensSemantic proximity Read ↗

Virus-Like Particles Expressing the Nucleocapsid Gene as an Efficient Vaccine Against Rift Valley Fever VirusSemantic proximity Read ↗

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteinsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.